1. Huang D, Wang J, Lin CP, et al. Micron-resolution ranging of cornea and anterior chamber by optical reflectometry. Lasers Surg Med. 11:1991; 419–25.
2. Swanson EA, Huang D, Hee MR, et al. High-speed optical coherence domain reflectometry. Opt Lett. 17:1992; 151–3.
Article
3. Hee MR, Huang D, Swanaon EA, Fujimoto JG. Polarization sensitive low coherence reflectometer for birefringence characterization and ranging. J Opt Soc Am. 1992; 9:903–8.
4. Kahn HA, Leibowitz HM, Ganley JP, et al. The framingham eye study. I. Outline and major prevalence findings. Am J Epidemiol. 1977; 106:17–41.
5. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99:933–43.
6. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98:1128–34.
Article
7. Ferris FL. Senile macular degeneration: Review of epidemiologic features. Am J Epidemiol. 1983; 118:132–5.
Article
8. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol. 1991; 109:1109–14.
9. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol. 1994; 112:500–9.
10. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol. 1993; 111:1200–9.
11. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994; 112:480–8.
12. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial-TAP report. Arch Ophthalmol. 1999; 117:1329–45.
13. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001; 131:541–60.
14. Salinas-Alaman A, Garcia-Layana A, Maldonado MJ, et al. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. Am J Ophthalmol. 2005; 140:23–8.
15. Roger AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 2002; 134:566–76.
16. Ting TD, Oh M, Cox TA, et al. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol. 2002; 120:731–7.
Article
17. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina. 2003; 23:159–65.
Article
18. Fukuchi T, Takahashi K, Ida H, et al. Staging of idiopathic choroidal neovascularization by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2001; 239:424–9.
Article
19. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular disease with optical coherence tomography. Ophthalmology. 1995; 102:217–29.
20. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology. 1996; 103:1260–70.
Article
21. Brancato R, Introini U, Bolognesi G, et al. ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Retina. 2000; 20:134–42.
Article
22. Berkow JW, Flower RW, Orth DH, Kelley JS. Flourescein and Indocyanine Green Angiography-Technique and Interpretation, 2nd ed. Vol. 1. San Francisco, CA: American Academy of Ophthalmology. 1997; 5:91–103.
23. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998; 236:365–74.
Article
24. Nicole Eter, Richard FS. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photohynamic therapy. Retina. 2005; 25:691–6.
25. Arias L, Garcia-Arumi J, Ramon JM, et al. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Graefes Arch Clin Exp Ophthalmol. 2008; 246:245–54.
Article